Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.
Issue link: http://todaysveterinarypractice.epubxp.com/i/38074
ADVANCES IN STEM CELL THERAPY | 29. Brzoska M, Geiger H, Gauer S, Baer P. Epithelial differentiation of human adipose tissue-derived adult stem cells. Biochem Biophys Res Commun 2005; 330:142-150. 30. Trottier V, Marceau-Fortier G, Germain L, et al. IFATS collection: Using human adipose- derived stem/stromal cells for the production of new skin substitutes. Stem Cells 2008; 26:2713-2723. 31. Zuk P. Retrospective: The adipose-derived stem cell: Looking back and looking ahead. Mol Biol Cell 2010; June 21:1782-1787. 32. Tobita M, Orbay H, Mizuno H. Adipose- derived stem cells: Current findings and future perspectives. Discovery Medicine 2011; 11(57):160-170. 33. Gimble J, Katz AJ, Bunnel B. Adipose-derived stem cells for regenerative medicine. Circ Res 2007; 100:1249-1260. 34. Gimble J. Adipose tissue-derived therapeutics. Expert Opin Biol Ther 2003; 3:705-713. 35. Marx R, Garg A. Dental and Craniofascial Applications of Platelet-Rich Plasma. Hanover, IL: Quintessence Publishing Co, Inc, 2005. 36. Mishra A, Woodall J, Viera A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med 2009; 28(1):113-125. 37. Foster T, Puskas B, Mandelbaum B, et al. Platelet-rich plasma: From basic science to clinical applications. Amer J Sports Med 2009; 37(11):2259-2272. 38. Haynesworth SE, Kadiyala S, Liang LN, et al. Mitogenic stimulation of human mesenchymal stem cells by platelet release suggest a mechanism for enhancement of bone repair by platelet concentrates. Proc Ortho Res Soc, 2002. 39. Creaney L, Hamilton B. Growth factor delivery methods in the management of sports injuries: The state of play. Br J Sports Med 2008; 42:314-320. 40. Marx R, Kevy S, Jacobson M. Platelet rich plasma (PRP): A primer. Practical Pain Management 2008; 8(2). 41. El-Sharkawy H, Kantarci A, Deady J, et al. Platelet-rich plasma: Growth factors and pro- and anti-inflammatory properties. J Periodontol 2007; 78(4):661-669. 42. Little D, Guilak F, Ruch D. Ligament-derived matrix stimulates a ligamentous phenotype in human adipose-derived stem cells. Tissue Engineering: Part A 2009; 16(7):2307-2319. 43. Che X, Zou X, Yin G, Ouyang H. Tendon tissue engineering with mesenchymal stem cells and biografts: An option for large tendon defects? Front Biosci (School Ed) 2009; 1(1):23-32. 44. Uysal AC, Mizuno H. Tendon regeneration and repair with adipose derived stem cells. Curr Stem Cell Res Ther 2010; 5(2):161-167. 45. Uysal AC, Mizuno H. Differentiation of adipose-derived stem cells for tendon repair. Methods Mol Biol 2011; 702:443-451. 46. Uysal AC, Mizuno H. Tendon regeneration and repair with adipose derived stem cells. Curr Stem Cell Res Ther 2010; 5(2):161-167. 47. Jung M, Kaszap B, Redohl A, et al. Enhanced early tissue regeneration after matrix-assisted autologous mesenchymal stem cell transplantation in full thickness chondral defects in a minipig model. Cell Transplantation 2009; 18(8):923-932. 48. Lee K, Hui J, Song I, et al. Injectable mesenchymal stem cell therapy for large cartilage defects—a porcine model. Stem Cells 2007; 25:2965-2971. 49. Dragoo JL, Samimi B, Zhu M, et al. Tissue- engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br 2003; 85:740-747. 50. Hsu WK, Wang JC, Liu NQ, et al. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model. J Bone Joint Surg Am 2008; 90:1043- 1052. 51. Bacou F, el Andalousi RB, Daussin PA, et al. Transplantation of adipose tissue-derived stromal cells increases mass and functional capacity of damaged skeletal muscle. Cell Transplant 2004; 13:103-111. 52. Rodriguez LV, Alfonso Z, Zhang R, et al. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci USA 2006; 108:12167-12172. 53. Goudenege S, Pisani DF, Wdziekonski B, et al. Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. Mol Ther 2009; 17:1064-1072. 54. Santiago LY, Clavijo-Alvarez J, Brayfield C, et al. Delivery of adipose-derived precursor cells for peripheral nerve repair. Cell Transplant 2009; 18(2):145-158. 55. Di Summa PG, Kingham PJ, Raffoul W, et al. Adipose-derived stem cells enhance peripheral nerve regeneration. J Plast Reconstr Aesthet Surg 2010; 63(9):1544- 1552. 56. Nakada A, Fukuda S, Ichihara S, et al. Regeneration of central nervous tissue using a collagen scaffold and adipose-derived stromal cells. Cells Tissues Organs 2009; 190:326-335. 57. Cowan CM, Shi YY, Aalami OO, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004; 22:560-567. 58. Dudas JR, Marra KG, Cooper GM, et al. The osteogenic potential of adipose-derived stem cells for the repair of rabbit calvarial defects. Ann Plast Surg 2006; 56:543-548. 59. Yoon E, Dhar S, Chun D, et al. In vivo osteogenic potential of human adipose- derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 2007; 13:619-627. 60. Rosenbaum A, Grande D, Dines J. The use of mesenchymal stem cells in tissue engineering: A global assessment. Organogenesis 2008; 4(1):23-37. 61. Cousin B, Andre M, Arnaud E, et al. Reconstitution of lethally irradiated mice by cells isolated from adipose tissue. Biochem Biophys Res Commun 2003; 21:1016-1022. 62. Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129:118-129. 63. Kim WS, Park BS, Sung JH, et al. Wound healing effect of adipose-derived stem cells: A critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007; 48(1):15-24. 64. Ebrahimian TG, Pouzoulet F, Squiban C, et al. Cell therapy based on adipose tissue- derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol 2009; 29(4):503-510. 65. Trottier V, Marceau-Fortier G, Germain L, et al. IFATS collection: Using human adipose- derived stem/stromal cells for the production of new skin substitutes. Stem Cell 2008; 26:2713-2723. 66. Liang L, Mat T, Chen W, et al. Therapeutic potential and related signal pathway of adipose-derived stem cell transplantation for rat liver injury. Hepatol Res 2009; 39:822- 832. 67. Deng W, Han Q, Lia L, et al. Mesenchymal stem cells regenerate skin tissue. Tissue Engineering 2005; 11:110-119. 68. Long JL, Zuk P, Berke GS, Chhetri DK. Epithelial differentiation of adipose-derived stem cells for laryngeal tissue engineering. Laryngoscope 2009:125-131. 69. Park BS, Jang KA, Sung JH, et al. Adipose- derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatol Surg 2008; 34:1323-1326. 70. Okura H, Matsuyama A, Lee CM, et al. Cardiomyoblast-like cells differentiated from human adipose tissue-derived mesenchymal stem cells improve left ventricular dysfunction and survival in a rat myocardial infarction model. Tissue Eng Part C Methods 2010; 16(3):417-425. 71. Gonzalez-Rey E, Gonzalez MA, Varela N, et al. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 2010; 69:241-248. 72. Lin G, Wang G, Liu G, et al. Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. Stem Cells Dev 2009; 18:1399- 1406. 73. Lee ST, Chu K, Jung KH, et al. Slowed progression in models of Huntington disease by adipose stem cell transplantation. Ann Neurol 2009; 66:671-681. 74. Riordan NH, Ichim TE, Min WP, et al. Non- expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med 2009; 7:29. 75. Lin G, Wang G, Banie L, et al. Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy 2010; 12:88-95. 76. Mizuno H. Adipose-derived stem cells for tissue repair and regeneration. Ten years of research and a literature review. J Nippon Med Sch 2009; 76(2):56-66. 77. Fraser JK, Wulur I, Alfonso Z, et al. Fat tissue: An underappreciated source of stem cells for biotechnology. Trends Biotechol 2006; 24:150-154. 78. Strem B, Hicok K, Zhu M, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005; 54:132-139. 79. Prockop D, Phinney D, Bunnell B. Mesenchymal Stem Cells, Methods and Protocols. Clifton, NJ: Humana Press, 2008. 80. Alexander B. Autologous fat grafts as mesenchymal stormal stemcell source for use in prolotherapy: A simple technique to acquire lipoaspirants. J Prolother, August 2011. 81. Metallo C, Mohr J, Detzel C, et al. Engineering the stem cell microenvironment. Biotechnol Prog 2007; 23:18-23. Suggested Reading Alderman D. The new age of prolotherapy. Practical Pain Management, May 2010. July/August 2011 Today’s Veterinary Practice 29